{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Pomalidomide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pomalidomide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pomalidomide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "pomalidomide",
    "trial_2_text": "Pomalidomide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Pomalidomide Supplement: 60 participants will take Pomalidomide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pomalidomide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pomalidomide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.43254366517066956,
      "17": 0.31410402059555054,
      "173": 0.3102661967277527,
      "78": 0.305971622467041,
      "77": 0.29990360140800476,
      "9": 0.2950190603733063,
      "21": 0.290727436542511,
      "177": 0.28653404116630554,
      "20": 0.27898964285850525,
      "123": 0.27373144030570984,
      "64": 0.2728382349014282,
      "37": 0.24500349164009094,
      "2": 0.2346271276473999,
      "114": 0.2032686173915863,
      "239": 0.1946227103471756,
      "67": 0.18740521371364594,
      "85": 0.18202586472034454,
      "104": 0.17552195489406586,
      "189": 0.17044688761234283,
      "243": 0.16778308153152466,
      "14": 0.16606348752975464,
      "188": 0.16210806369781494,
      "46": 0.16159921884536743,
      "79": 0.15964852273464203,
      "200": 0.15675713121891022,
      "228": 0.15581712126731873,
      "49": 0.14723911881446838,
      "126": 0.14561372995376587,
      "68": 0.1440323293209076,
      "116": 0.1421840935945511,
      "86": 0.14178767800331116,
      "139": 0.14121763408184052,
      "131": 0.1338152140378952,
      "38": 0.13027839362621307,
      "350": 0.12914860248565674,
      "101": 0.12744492292404175,
      "30": 0.12558403611183167,
      "288": 0.12462513893842697,
      "180": 0.1233331710100174,
      "29": 0.12283853441476822,
      "179": 0.12176381051540375,
      "396": 0.11730938404798508,
      "76": 0.116461381316185,
      "5": 0.11582417786121368,
      "61": 0.1135072410106659,
      "92": 0.11238446086645126,
      "27": 0.11083042621612549,
      "72": 0.10939990729093552,
      "82": 0.10188759863376617,
      "122": 0.0981142595410347,
      "253": 0.09775513410568237,
      "204": 0.09517126530408859,
      "35": 0.09503880143165588,
      "211": 0.09479069709777832,
      "466": 0.09329906851053238,
      "69": 0.09292096644639969,
      "28": 0.09210891276597977,
      "18": 0.09195969253778458,
      "286": 0.09170302748680115,
      "102": 0.09055916219949722,
      "441": 0.08919978886842728,
      "98": 0.08406959474086761,
      "261": 0.08264380693435669,
      "4": 0.08156346529722214,
      "456": 0.07991738617420197,
      "221": 0.0794111043214798,
      "454": 0.07901297509670258,
      "356": 0.07893761992454529,
      "249": 0.07739242166280746,
      "151": 0.07648126035928726,
      "194": 0.07602538913488388,
      "144": 0.0759129673242569,
      "75": 0.07552086561918259,
      "212": 0.07544536143541336,
      "36": 0.07531531155109406,
      "186": 0.07481691986322403,
      "489": 0.07472160458564758,
      "193": 0.07395302504301071,
      "96": 0.0732995867729187,
      "147": 0.07239225506782532,
      "276": 0.0722009688615799,
      "135": 0.0717044398188591,
      "136": 0.07132191210985184,
      "361": 0.0710083395242691,
      "355": 0.07032478600740433,
      "269": 0.06940854340791702,
      "195": 0.06859887391328812,
      "138": 0.06824371218681335,
      "163": 0.06823152303695679,
      "535": 0.06756898015737534,
      "132": 0.06752676516771317,
      "382": 0.06463482975959778,
      "11": 0.06432972848415375,
      "256": 0.06330915540456772,
      "166": 0.06276680529117584,
      "1": 0.06203227862715721,
      "282": 0.06185445562005043,
      "268": 0.06126723438501358,
      "397": 0.06080546975135803,
      "89": 0.06055494025349617
    },
    "trial_2_ae": {
      "87": 0.43254366517066956,
      "17": 0.31410402059555054,
      "173": 0.3102661967277527,
      "78": 0.305971622467041,
      "77": 0.29990360140800476,
      "9": 0.2950190603733063,
      "21": 0.290727436542511,
      "177": 0.28653404116630554,
      "20": 0.27898964285850525,
      "123": 0.27373144030570984,
      "64": 0.2728382349014282,
      "37": 0.24500349164009094,
      "2": 0.2346271276473999,
      "114": 0.2032686173915863,
      "239": 0.1946227103471756,
      "67": 0.18740521371364594,
      "85": 0.18202586472034454,
      "104": 0.17552195489406586,
      "189": 0.17044688761234283,
      "243": 0.16778308153152466,
      "14": 0.16606348752975464,
      "188": 0.16210806369781494,
      "46": 0.16159921884536743,
      "79": 0.15964852273464203,
      "200": 0.15675713121891022,
      "228": 0.15581712126731873,
      "49": 0.14723911881446838,
      "126": 0.14561372995376587,
      "68": 0.1440323293209076,
      "116": 0.1421840935945511,
      "86": 0.14178767800331116,
      "139": 0.14121763408184052,
      "131": 0.1338152140378952,
      "38": 0.13027839362621307,
      "350": 0.12914860248565674,
      "101": 0.12744492292404175,
      "30": 0.12558403611183167,
      "288": 0.12462513893842697,
      "180": 0.1233331710100174,
      "29": 0.12283853441476822,
      "179": 0.12176381051540375,
      "396": 0.11730938404798508,
      "76": 0.116461381316185,
      "5": 0.11582417786121368,
      "61": 0.1135072410106659,
      "92": 0.11238446086645126,
      "27": 0.11083042621612549,
      "72": 0.10939990729093552,
      "82": 0.10188759863376617,
      "122": 0.0981142595410347,
      "253": 0.09775513410568237,
      "204": 0.09517126530408859,
      "35": 0.09503880143165588,
      "211": 0.09479069709777832,
      "466": 0.09329906851053238,
      "69": 0.09292096644639969,
      "28": 0.09210891276597977,
      "18": 0.09195969253778458,
      "286": 0.09170302748680115,
      "102": 0.09055916219949722,
      "441": 0.08919978886842728,
      "98": 0.08406959474086761,
      "261": 0.08264380693435669,
      "4": 0.08156346529722214,
      "456": 0.07991738617420197,
      "221": 0.0794111043214798,
      "454": 0.07901297509670258,
      "356": 0.07893761992454529,
      "249": 0.07739242166280746,
      "151": 0.07648126035928726,
      "194": 0.07602538913488388,
      "144": 0.0759129673242569,
      "75": 0.07552086561918259,
      "212": 0.07544536143541336,
      "36": 0.07531531155109406,
      "186": 0.07481691986322403,
      "489": 0.07472160458564758,
      "193": 0.07395302504301071,
      "96": 0.0732995867729187,
      "147": 0.07239225506782532,
      "276": 0.0722009688615799,
      "135": 0.0717044398188591,
      "136": 0.07132191210985184,
      "361": 0.0710083395242691,
      "355": 0.07032478600740433,
      "269": 0.06940854340791702,
      "195": 0.06859887391328812,
      "138": 0.06824371218681335,
      "163": 0.06823152303695679,
      "535": 0.06756898015737534,
      "132": 0.06752676516771317,
      "382": 0.06463482975959778,
      "11": 0.06432972848415375,
      "256": 0.06330915540456772,
      "166": 0.06276680529117584,
      "1": 0.06203227862715721,
      "282": 0.06185445562005043,
      "268": 0.06126723438501358,
      "397": 0.06080546975135803,
      "89": 0.06055494025349617
    }
  },
  "safety": {
    "trial_1_safety": 0.5872533917427063,
    "trial_2_safety": 0.5872533917427063
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48031139373779297
  }
}